Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-22

Clinical Trial Update: Effects of n-3 Polyunsaturated Fatty Acids and Antioxidants on Postprandial Hyperlipidemia and Vascular Function in Men [Phase 2, Phase 3]

View source ↗

Summary

Completed Phase 2/Phase 3 clinical trial evaluating the effects of omega-3 polyunsaturated fatty acids and antioxidants on postprandial lipids and vascular func…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antioxidants (unspecified)
  • Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Laval University | Conditions: Cardiovascular Diseases, Vasodilation | Phase 2, Phase 3 | Status: COMPLETED